GlobeNewswire PharmaOriginal article
Eledon Presents Updated Long-Term Phase 2 BESTOW Extension Study Results at the International Congress of The Transplantation Society
Data ReadoutNeutral
AI Analysis
Summary
Eledon presented updated long-term Phase 2 BESTOW extension study results at the International Congress of The Transplantation Society.
Clinical Trial Data
Phase
Phase_2
Importance:5/10
Sentiment:
0.00
Phase 2extension studytransplantationBESTOWconference presentation
Related Companies
Read the original article
Published by GlobeNewswire Pharma on September 22, 2026 11:00 AM